Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

RCAS1 anticorps

EBAG9 Reactivité: Humain IF, IHC (f) Hôte: Souris Monoclonal CPTC-EBAG9-1 unconjugated
N° du produit ABIN6937120
  • Antigène Voir toutes RCAS1 (EBAG9) Anticorps
    RCAS1 (EBAG9) (Estrogen Receptor Binding Site Associated, Antigen, 9 (EBAG9))
    Reactivité
    • 36
    • 32
    • 13
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 41
    • 8
    • 2
    Souris
    Clonalité
    • 42
    • 9
    Monoclonal
    Conjugué
    • 25
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp RCAS1 est non-conjugé
    Application
    • 22
    • 16
    • 13
    • 13
    • 9
    • 5
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    Immunofluorescence (IF), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
    Specificité
    EBAG9, also known as RCAS1, is an estrogen-transcribed protein. Soluble and membranous RCAS1 proteins may play a role in the immune escape of tumor cells by promoting T lymphocyte inhibition of growth and apoptosis. RCAS1 is expressed in a wide variety of cancers, including uterine, ovarian, and lung cancer cells, and acts as a ligand for a putative receptor present on peripheral lymphocytes. RCAS1 is highly expressed not only in cancer cells but also in non-tumor bile duct cells subject to immune attack. RCAS1 inhibits the in vitro growth of receptor-expressing cells and induces apoptosis, contributing to the ability of tumor cells to evade host immune surveillance. High expression of RCAS1 significantly correlates with tumor progression and with poor outcome for many cancer patients.
    Réactivité croisée (Details)
    Human.
    Purification
    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.
    Immunogène
    Recombinant human full-length EBAG9 protein
    Clone
    CPTC-EBAG9-1
    Isotype
    IgG2c kappa
    Top Product
    Discover our top product EBAG9 Anticorps primaire
  • Indications d'application

    Known_Application: Immunofluorescence (1-2 μg/mL),Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 min at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Positive_Control: MCF-7, Jurkat, 293 cell lysates, Human skeletal muscle tissue.

    Restrictions
    For Research Use only
  • Concentration
    1.0 mg/mL
    Buffer
    Prepared in 10 mM PBS, WITHOUT BSA and Azide.
    Agent conservateur
    Azide free
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.
    Date de péremption
    24 months
  • Antigène
    RCAS1 (EBAG9) (Estrogen Receptor Binding Site Associated, Antigen, 9 (EBAG9))
    Autre désignation
    EBAG9 (EBAG9 Produits)
    Synonymes
    anticorps EB9, anticorps PDAF, anticorps MGC56608, anticorps zgc:56608, anticorps MGC84425, anticorps EBAG9, anticorps AI835379, anticorps Rcas1, anticorps RCAS1, anticorps eb9, anticorps pdaf, anticorps rcas1, anticorps estrogen receptor binding site associated, antigen, 9, anticorps estrogen receptor binding site associated, antigen, 9 L homeolog, anticorps estrogen receptor-binding fragment-associated gene 9, anticorps EBAG9, anticorps ebag9, anticorps ebag9.L, anticorps Ebag9
    Sujet
    BAG9, cancer associated surface antigen, cancer associated surface antigen RCAS1, EB9, estrogen receptor binding fragment associated gene 9, PDAF, receptor binding cancer antigen expressed on SiSo cells,RCAS1 / Estrogen Receptor Binding Site Associated, Antigen 9
    Cellular localisation: Golgi apparatus.
    Poids moléculaire
    32kDa
    ID gène
    9166, 409368
    UniProt
    O00559
Vous êtes ici:
Support technique